Guardian Pharmacy Services, Inc. (GRDN)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
---|---|---|---|---|
Revenues | 344,334 | 329,308 | 314,393 | |
Cost of goods sold | 276,188 | 264,959 | 253,515 | |
Gross profit | 68,146 | 64,349 | 60,878 | |
Selling, general, and administrative expenses | 55,566 | 51,344 | 165,491 | |
Operating income | 12,580 | 13,005 | -104,613 | |
Other expense (income), net | 179 | 271 | -2 | |
Interest expense | 172 | 170 | 1,026 | |
Total other expenses (income) | 7 | 101 | -1,028 | |
Income before income taxes | 12,587 | 13,106 | -105,641 | |
Provision for income taxes | 3,760 | 3,833 | 176 | |
Net income | 8,827 | 9,273 | -105,817 | |
Less net income (loss) attributable to non-controlling interests | -203 | -175 | 6,823 | |
Less net income attributable to guardian pharmacy, llc prior to the corporate reorganization | - | - | 9,350 | |
Net income attributable to guardian pharmacy services, inc | 9,030 | 9,448 | -121,990 | |
Basic eps | - | 0.15 | -2 | |
Diluted eps | - | 0.15 | -2 | |
Basic average shares | - | 62,043,311 | 61,143,311 | |
Diluted average shares | - | 62,914,077 | 61,143,311 |